NCC-164

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNCC-164
Drug Alias NameNCC-164
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHIV replication inhibitors
TargetsUpdating
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNippon Chemiphar Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNippon Chemiphar Co Ltd
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A